Our mission is to advance cancer prevention, diagnosis, treatment, and cure through collaborative research while providing expert care to children and adults.
About HCC
Our Mission
The Harvard Cancer Consortium is an NCI-designated comprehensive cancer center, and one of the largest cancer research enterprises in the world.
Founded to integrate and build upon the collective talent and resources of the Harvard cancer research community, HCC is comprised of five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health. Together we combine our scientific strengths to create a rich, collaborative environment that transcends institutional borders.
HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973. Today, more than 1,100 HCC cancer researchers work together in innovative clinical-, translational-, basic-, and population-based research programs. Our members receive in excess of $600 million in cancer research funding. Cost-effective shared facilities, or centralized core laboratories, enable access to cutting edge technologies and allow us to build world-class scientific archives. Our members are training and educating the next generation of cancer researchers, and thousands of patients are being enrolled in our clinical trials.
Our strength is in our numbers.
Harvard Cancer Consortium (HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community.
Beth Israel Deaconess Medical Center(opens in new window)
Boston Children's Hospital(opens in new window)
Brigham and Women's Hospital(opens in new window)
Dana-Farber Cancer Institute(opens in new window)
Harvard Medical School(opens in new window)
Harvard T.H. Chan School of Public Health(opens in new window)- Massachusetts General Hospital(opens in new window)
Leadership & Administration
Cancer Center
Benjamin L. Ebert, MD, PhD
Director
Ramesh A. Shivdasani, MD, PhD
Executive Director
David P. Ryan, MD
Deputy Director
David Ting, MD
Deputy Executive Director
Administration
Deborah J. Goff, PhD
Associate Director
Kelsey Laning, MS
Deputy Associate Director
Basic Science
Karen Adelman, PhD
Associate Director
Cancer Research Training and Education
Lee M. Nadler, MD
Associate Director
Clinical Science
David E. Avigan, MD
Co-Associate Director
Paul L. Nguyen, MD MBA FASTRO FASCO
Co-Associate Director
Clinical Trials
Jeffrey A. Meyerhardt, MD, MPH
Co-Associate Director
Matthew J Frigault, MD
Co-Associate Director
Community Outreach and Engagement
Vish Viswanath, PhD
Co-Associate Director
Elsie M. Taveras, MD, MPH
Co-Associate Director
Christopher S. Lathan, MD, MS, MPH
Deputy Associate Director
Developmental Funds
Stephen C. Blacklow, MD, PhD
Associate Director
Membership
Nadine M. Tung, MD
Associate Director
Jon C. Aster, MD, PhD
Deputy Associate Director
Erica T. Warner, ScD, MPH
Deputy Associate Director
Population Science
Lorelei A. Mucci, MPH, ScD
Associate Director
Breast Cancer
Cancer Care Delivery Research
Cancer Cell Biology
Cancer Data Sciences
Cancer Epidemiology
Cancer Genetics and Epigenetics
Cancer Immunology
Cancer Risk, Prevention, and Early Detection
Developmental Therapeutics
Gastrointestinal Malignancies
Gynecologic Cancers
Kidney Cancer
Leukemia
Lung Cancer
Lymphoma and Myeloma
Melanoma
Neuro-Oncology
Prostate Cancer
Bioinformatics Training
Shannan Ho Sui, PhD
Director
Will Gammerdinger, PhD
Co-Director
Biostatistics
Nabihah Tayob, PhD
Director
Cancer Proteomics
Towia A. Libermann, PhD
Director
John M. Asara, PhD
Co-Director
Cell Manipulation
Jose Cancelas-Perez, MD, PhD
Executive Director
Jerome Ritz, MD
Executive Director
Sarah Nikiforow, MD, PhD
Medical Director
Health Communication
Vish Viswanath, PhD
Director
Mouse Engineering
Arlene H. Sharpe, MD, PhD
Director
Research Pharmacy
Sylvia Bartel, MPH
Director
Spatial Technologies Unit
Ioannis S Vlachos, PhD
Director
Shuoshuo Wang, PhD
Scientific Director
Survey and Qualitative Methods
Wendy B. London, PhD
Director
Tumor Imaging Metrics
Gordon J. Harris, PhD
Co-Director
Annick D. Van den Abbeele, MD, FACR, FICIS
Co-Director
| Name | Title | Phone | ||
|---|---|---|---|---|
| Administration | ||||
| Deborah J Goff, PhD | Vice President, HCC Administration | (617) 632-4044 | ||
| Amanda Smith | Executive Assistant for Ramesh Shivdasani | (617) 632-3487 | ||
| Laura Bridge | Lead Research Administrator | |||
| Mark Grinstein-Camacho | HCC Administrative Specialist | |||
| Communications | ||||
| Richard Oakley | Communications Director | (617) 632-4276 | ||
| Rosemary Nabukeera | Sr. Communications Specialist | |||
| Daniel Pabon | Communications Specialist | |||
| Community Outreach & Engagement | ||||
| Sara Minski, MPH | Assistant Director | |||
| Jennifer Reiner, MPH | Senior Program Manager | |||
| Core Facilities | ||||
| Jun-Rong Wei, PhD | Director for Core Facilities | |||
| Kelly Smith | Program Manager | (617) 632-4104 | ||
| CURE Program | ||||
| Brittany Michel, PhD | Associate Director | |||
| Teresa Acosta | Program Manager | |||
| Christopher Hogan | Research Training Specialist | |||
| Informatics | ||||
| Thomas Leonard | Web Systems Architect | (617) 632-3937 | ||
| Membership, Program Coordination, and Operations | ||||
| Jun-Rong Wei, PhD | Director, HCC Operations | |||
| Jackie Hwang | Program Manager | (617) 632-5685 | ||
| Pathfinder | ||||
| Elizabeth Salomon, EdM | Senior Program Manager | |||
| Isabel Lam, PhD | Program Administrator | |||
HCC Offices
Research Support Offices
CRTEC
Pathfinder Office
Pathfinder has concentrated its efforts on developing support for HCC-affiliated trainees.
COE
Community Outreach & Engagement
COE is the bridge between Harvard Cancer Consortium (HCC) and the communities of Massachusetts.HCC Administration
Learn more about the central administrative resources and services available to our members.OHRS
Office for Human Research Studies
The Office for Human Research Studies (OHRS) protects the rights and safety of our research subjects while facilitating research excellence. We oversee scientific and Institutional Review Board review processes for the HCC.
ODQ
Office of Data Quality
At the Harvard Cancer Consortium, our investigators are renowned for cutting-edge and ground-breaking science. The ODQ brings that same innovative spirit to clinical research quality and operations.
RIO
Research Informatics Operations
Research Informatics Operations (RIO) specifically addresses the growing technological needs of the clinical trials research community. The office provides a collaborative, responsive, integrated and focused approach to all aspects of systems development and support.
Ways of Giving
Find out more about how to support the Cancer Center:
Rebecca Gavin
HCC Development Office
10 Brookline Place, West, 5th Floor
Brookline, MA 02445
(617) 632-3491